The Board denied service connection for prostate carcinoma and malignant neoplasm of intrapelvic lymph nodes, finding no evidence linking the conditions to active duty or exposure at Camp Lejeune.
The deciding factor: The September 2024 VA examination opined that both the prostate cancer and lymph nodes cancer were less likely than not related to in-service toxic exposure risk activities (TERA) due to a lack of medical evidence supporting such a relationship, and because other factors like age and family history outweighed any potential TERA-related risks.
- Claimed conditions
- prostate carcinoma (prostate cancer), malignant neoplasm of intrapelvic lymph nodes (lymph nodes cancer)
- How they argued it
- Direct service connection
- Exposure basis
- Camp Lejeune water
- Rating assigned
- None in this decision
- Decision date
- October 30, 2025
- Citation
- A25094423
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.